FDA Approves METHOTREXATE SODIUM — Elite Laboratories, Inc.

# FDA Approves Elite Laboratories' Generic Methotrexate Sodium Oral Formulation Elite Laboratories, Inc. has received FDA approval for its generic methotrexate sodium oral formulation (ANDA216453), expanding the competitive generic market for this widely-used immunosuppressant and anticancer drug. The approval is expected to increase treatment accessibility and potentially lower costs for patients relying on methotrexate for conditions including rheumatoid arthritis, cancer, and autoimmune disorders.